12 generalized immune activation in HIV controllers,” PLoS ONE, vol. 6, no. 1, Article ID e15924, 2011. [107] L. Wang, Y. Xie, L. J. Zhu, T. T. Chang, Y. Q. Mao, and J. Li, “An association between immunosenescence and CD4+CD25+ regulatory T cells: a systematic review,” Biomed- ical and Environmental Sciences, vol. 23, no. 4, pp. 327–332, 2010. [108] E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmen- tal pathways for the generation of pathogenic eﬀector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235– 238, 2006. [109] D. Favre, S. Lederer, B. Kanwar et al., “Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection,” PLoS Pathogens, vol. 5, no. 2, Article ID e1000295, 2009. [110] D. Favre, J. Mold, P. W. Hunt et al., “Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease,” Science Translational Medicine, vol. 2, no. 32, article 32ra36, 2010. [111] P. W. Hunt, “Th17, gut, and HIV: therapeutic implications,” Current Opinion in HIV and AIDS, vol. 5, no. 2, pp. 189–193, 2010. [112] D. J. Hartigan-O’Connor, L. A. Hirao, J. M. McCune, and S. Dandekar, “Th17 cells and regulatory T cells in elite control over HIV and SIV,” Current Opinion in HIV and AIDS, vol. 6, no. 3, pp. 221–227, 2011. [113] M. Salgado, N. I. Rallon, B. Rodes, M. Lopez, V. Soriano, and J. M. Benito, “Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors,” Clinical Immunology, vol. 139, no. 2, pp. 110–114, 2011. [114] L. Wang, C. W. Robb, and M. W. Cloyd, “HIV induces hom- ing of resting T lymphocytes to lymph nodes,” Virology, vol. 228, no. 2, pp. 141–152, 1997. [115] L. Wang, J. J. Y. Chen, B. B. Gelman, R. Konig, and M. W. Cloyd, “A novel mechanism of CD4 lymphocyte depletion involves eﬀects of HIV on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors,” Journal of Immunology, vol. 162, no. 1, pp. 268–276, 1999. [116] M. W. Cloyd, J. J. Y. Chen, P. Adeqboyega, and L. Wang, “How does HIV cause depletion of CD4 lymphocytes? A mecha- nism involving virus signaling through its cellular receptors,” Current Molecular Medicine, vol. 1, no. 5, pp. 545–550, 2001. [117] H. J. Epple, C. Loddenkemper, D. Kunkel et al., “Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART,” Blood, vol. 108, no. 9, pp. 3072–3078, 2006. [118] J. M. Shaw, P. W. Hunt, J. W. Critchﬁeld et al., “Increased fre- quency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers,” Journal of Virology, vol. 85, no. 21, pp. 1122–1134, 2011. [119] J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer, “Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection,” Nature, vol. 434, no. 7037, pp. 1093–1097, 2005. [120] M. Guadalupe, E. Reay, S. Sankaran et al., “Severe CD4+ T- cell depletion in gut lymphoid tissue during primary human immunodeﬁciency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy,” Journal of Virology, vol. 77, no. 21, pp. 11708–11717, 2003. [121] T. W. Schacker, P. L. Nguyen, G. J. Beilman et al., “Collagen deposition in HIV-1 infected lymphatic tissues and T cell AIDS Research and Treatment homeostasis,” Journal of Clinical Investigation, vol. 110, no. 8, pp. 1133–1139, 2002. [122] T. H. Finkel, G. Tudor-Williams, N. K. Banda et al., “Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes,” Nature Medicine, vol. 1, no. 2, pp. 129–134, 1995. [123] G. Pantaleo, S. Menzo, M. Vaccarezza et al., “Studies in sub- jects with long-term nonprogressive human immunodeﬁ- ciency virus infection,” New England Journal of Medicine, vol. 332, no. 4, pp. 209–216, 1995. [124] J. M. Brenchley and D. C. Douek, “The mucosal barrier and immune activation in HIV pathogenesis,” Current Opinion in HIV and AIDS, vol. 3, no. 3, pp. 356–361, 2008. [125] J. M. Brenchley, T. W. Schacker, L. E. Ruﬀ et al., “CD4+ T cell depletion during all stages of HIV disease occurs predomi- nantly in the gastrointestinal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 749–759, 2004. [126] S. Mehandru, M. A. Poles, K. Tenner-Racz et al., “Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from eﬀector sites in the gastrointesti- nal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 761–770, 2004. [127] E. Merlini, F. Bai, G. M. Bellistr`ı, C. Tincati, A. d’Arminio Monforte, and G. Marchetti, “Evidence for polymicrobic ﬂora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral ther- apy,” PLoS ONE, vol. 6, no. 4, Article ID e18580, 2011. [128] J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. [129] B. Ling, R. S. Veazey, M. Hart et al., “Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV- infected rhesus predicts long term non-progression,” AIDS, vol. 21, no. 18, pp. 2377–2385, 2007. [130] A. L. Ferre, P. W. Hunt, J. W. Critchﬁeld et al., “Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control,” Blood, vol. 113, no. 17, pp. 3978–3989, 2009. [131] A. L. Ferre, P. W. Hunt, D. H. McConnell et al., “HIV controllers with HLA-DRB1∗13 and HLA-DQB1∗06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses,” Journal of Virology, vol. 84, no. 21, pp. 11020–11029, 2010. [132] S. A. Migueles, J. C. Tilton, and M. Connors, “Advances in understanding immunologic control of HIV infection,” Current HIV/AIDS Reports, vol. 1, no. 1, pp. 12–17, 2004. [133] F. Porichis and D. E. Kaufmann, “HIV-speciﬁc CD4 T cells and immune control of viral replication,” Current Opinion in HIV and AIDS, vol. 6, no. 3, pp. 174–180, 2011. [134] P. Borrow, H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. A. Oldstone, “Virus-speciﬁc CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeﬁciency virus type 1 infection,” Journal of Virology, vol. 68, no. 9, pp. 6103–6110, 1994. [135] R. A. Koup, J. T. Safrit, Y. Cao et al., “Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeﬁciency virus type 1 syndrome,” Journal of Virology, vol. 68, no. 7, pp. 4650–4655, 1994. [136] N. L. Letvin, J. E. Schmitz, H. L. Jordan et al., “Cytotoxic T lymphocytes speciﬁc for the simian immunodeﬁciency virus,” Immunological Reviews, vol. 170, pp. 127–134, 1999.